Abstract
The tubulinopathies are an umbrella of rare diseases that result from mutations in tubulin genes and are frequently characterised by severe brain malformations. The characteristics of a given disease reflect the expression pattern of the transcript, the function of a given tubulin gene, and the role microtubules play in a particular cell type. Mouse models have proved to be valuable tools that have provided insight into the molecular and cellular mechanisms that underlie the disease state. In this manuscript we compare two Tuba1a mouse models, both of which express wild-type TUBA1A protein but employ different codon usage. We show that modification of the Tuba1a mRNA sequence results in homozygous lethality and a severe neurodevelopmental phenotype. This is associated with a decrease in the number of post-mitotic neurons, PAX6 positive progenitors, and an increase in the number of apoptotic cells. We attribute this to a decrease in the stability of the modified Tuba1a transcript, and the absence of compensation by the other neurogenic tubulins. Our findings highlight the importance of maintaining the wild-type coding sequence when engineering mouse lines and the impact of synonymous genetic variation.
Subject terms: Molecular biology, Neuroscience, Development of the nervous system, Diseases of the nervous system, Genetics of the nervous system
Introduction
Microtubules are long and hollow cylinders that participate in many fundamental cellular functions1. During mitosis, they make up the mitotic spindle, they act as a scaffold for intracellular trafficking and, because they are a component of cilia and flagella, they contribute to cell motility. To render such a diversity of mechanical tasks, microtubules undergo cycles of polymerisation and de-polymerisation, a stochastic behaviour termed ‘dynamic instability’2. They are assembled from α- and β-tubulin heterodimers that fold via a highly conserved and complex pathway involving chaperones, chaperonins and other co-factors3. One feature of microtubules is that α- and β-tubulins derive from a multi-gene family, which share a high degree of sequence homology with each other and with their orthologs. Nonetheless, the tubulin isoforms are distinctly different. They are encoded by genes on different chromosomes, their carboxy-terminal and 3’ untranslated-region are varied, and they have distinct and interesting expression patterns. To date much research has focused on the α-tubulin TUBA1A as it is highly expressed in the developing nervous system and de novo mutations cause a broad spectrum of diseases, including lissencephaly and microcephaly4–9. To gain insight into the underlying molecular pathology and function of TUBA1A investigators have exploited both spontaneous and mutant mouse models5,10,11. We have previously shown that a S140G mutation in mice causes defects in neuronal migration, and Stottmman and colleagues have reported that ablation of Tuba1a causes perinatal lethality in homozygous mice with severe brain malformations at E16.511. The generation of various reporter lines indicates that TUBA1A is highly expressed in post-mitotic neurons and is largely absent from progenitors12–14.
In addition to enhancer driven gene expression tubulin mRNA levels are controlled by an autoregulatory mechanism15,16. It has been shown that tubulin protein monomers influence the levels of tubulin mRNA, which is dependent on the first four amino acids of the protein (MREI motif)15–17. Lin and colleagues have recently demonstrated that this mechanism relies on the ribosome associated protein TTC5, which recognizes the MREI motif at the N-terminus of the tubulins and triggers degradation of tubulin mRNA18. Collectively these studies have highlighted the importance of tubulin mRNA stability, which in turn influences the cytoskeletal ecosystem of the cell. Here, we report the generation of a mouse line that carries an alternative codon sequence in exon 4 of Tuba1a19. We show that homozygotes expressing the modified Tuba1a mRNA present with a severe neurodevelopmental phenotype which is associated with a significant decrease in Tuba1a mRNA levels.
Results
Generation of two R402H Tuba1a conditional mouse lines
With the aim of studying the effects of a recurrent patient mutation (R402H) in TUBA1A, we designed a mouse line that permits the conditional expression of the R402H mutation19 (Fig. 1a, Supplementary Fig. 1). This line includes two copies of exon 4, with the wild-type sequence flanked by LoxP sites, followed by a second allele with the R402H mutation. In the first instance we changed the codon sequence of the WT allele, to limit promiscuous homologous recombination when targeting in ES cells. This line we will refer to as R402H Tuba1a (modified). We then created a second line that was identical in all respects, except the codon sequence was not modified, which we refer to as R402H Tuba1a (wt). For this study neither line was crossed with a Cre driver, and therefore the R402H mutation is not expressed19. We simply compare two lines that both express the wild-type TUBA1A protein, but one with modified codon usage. To confirm that the R402H mutation is not expressed we extracted mRNA from E16.5 embryos, and generated cDNA. Sanger sequencing showed that the R402H variant is not present in the mRNA pool and that the codon sequence was only altered in exon 4 in R402H Tuba1a (modified) mice (Fig. 1b). A sequence comparison revealed that the overall homology between the modified and the wild-type Tuba1a allele was 78.8%.
Perinatal lethality and impaired neurodevelopment in Tuba1a R402Hmod/R402Hmod homozygotes
We proceeded by analysing the phenotype of both R402H Tuba1a (wt) and R402H Tuba1a (modified) lines in the absence of Cre. To our surprise homozygous R402Hmod/R402Hmod mice did not survive until birth, so we collected E16.5 embryos from both lines (Fig. 2a–f, Supplementary Fig. 2). R402Hwt/R402Hwt animals are completely normal in all respects, are indistinguishable from controls (+/+), and survive until adulthood (Fig. 2a–c, Supplementary Fig. 2a–c)19. In contrast, R402Hmod/R402Hmod animals present with a severe neurodevelopmental phenotype (Fig. 2d-f–, Supplementary Fig. 2d–f). In comparison to wild-type controls and heterozygotes, these animals show an enlargement of the ventricles, cortical thinning and disorganization, and a reduction in the size of the striatum and thalamus (Fig. 2d–f).
Reduction in Ctip2 positive neurons and PAX6 positive progenitors in Tuba1a R402Hmod/R402Hmod homozygotes
To further assess the defects in brain morphology in the R402Hmod/R402Hmod animals, we stained with the neuronal marker Ctip2 which labels layer 5/6 neurons, the dominant neuronal population present at E16.5. Quantitation of layer thickness revealed no significant difference between homozygous R402Hwt/wt and littermate controls (n = 5; + / + vs. R402Hwt/+ , P > 0.05; +/+ vs. R402Hwt/R402Hwt, P > 0.05) (Fig. 3a–d). In contrast, there was significant reduction in the thickness of the Ctip2-positive neuronal cell layer when comparing homozygous R402Hmod/R402mod animals and littermate controls (n = 5 + / + vs. R402Hmod/mod p < 0.05) (Fig. 3e–h). To determine whether the neuroanatomical defects observed in homozygous R402Hmod/R402Hmod also affect neural progenitor cells, we stained for the progenitor marker Pax6 and quantified the thickness of the ventricular zone at E16.5. We observed no significant difference in VZ thickness between R402Hwt/wt and control littermates (n = 5; +/+ vs. R402Hwt/+ , P > 0.05; +/+ vs. R402Hwt/R402Hwt, P > 0.05) (Fig. 3i–l). In comparison, the thickness of the VZ is significantly reduced in homozygous R402mod/R402Hmod animals compared to heterozygous R402mod/R402H+ and wild-type control littermates (n = 5; +/+ vs. R402Hmod/mod, P < 0.01; R402Hmod/R402H+ vs. R402Hmod/mod, P < 0.05) (Fig. 3m–p). These data show that modification of the Tuba1a locus perturbs the architecture of the ventricular zone as well as altering neuronal cell layers.
Increase in apoptotic cells in Tuba1a R402Hmod/R402Hmod homozygotes
Mutations in Tuba1a have previously been associated with an increase in the number of apoptotic cells in mutant animals11. To assess whether homozygous R402Hmod/R402Hmod mice have increased apoptosis compared to control animals, we performed staining for the apoptotic cell marker cleaved caspase-3 and quantified the number of apoptotic cells in mutant and control mice. Homozygous R402Hwt/R402Hwt animals have very few capsase-3-positive cells similar to control littermates (Fig. 4a–d). In comparison, we observed many caspase-3-positive cells in homozygous R402Hmod/R402Hmod mice (Fig. 4e–g). Quantification revealed a significant increase in the number of apoptotic cells in R402Hmod/R402Hmod compared to heterozygous R402Hmod/R402H+ and wild-type littermates (n = 5; +/+ vs. R402mod/R402+, P < 0.01; R402mod/R402+ vs. R402Hmod/R402Hmod, P < 0.01) (Fig. 4h). These results demonstrate that expression of the modified Tuba1a allele leads to increased apoptosis during the development of the cortex.
Tuba1a mRNA levels are significantly reduced in homozygous R402Hmod/R402Hmod embryos
To gain insight into this phenotype, we assessed the expression levels of the neuronal α-tubulins: Tuba1a, Tuba1b, Tuba1c and Tuba4a (Fig. 5)20. We isolated the cortices of E16.5 embryos, extracted the RNA and performed qPCR on reverse transcribed cDNA. Using isoform-specific primers, we found that the levels of Tuba1a were slightly reduced in heterozygous R402Hwt/+ embryos compared to wild-type littermates although no differences were observed in homozygotes (n = 5; +/+ vs. R402Hwt/+ , P < 0.05; +/+ vs. R402Hwt/R402Hwt, P > 0.1) (Fig. 5a). We found no significant differences in the expression levels of Tuba1b, Tuba1c, and Tuba4a when comparing +/+ , R402Hwt/+ , and R402Hwt/R402Hwt littermates (See Supplementary Table S1). In contrast the transcript levels of Tuba1a were drastically reduced in both heterozygous and homozygous animals with the modified codon sequence (n = 5, +/+ vs. R402Hmod/+ P < 0.0001; +/+ vs. R402Hmod/R402Hmod P < 0.0001 and R402Hmod/+ vs. R402Hmod/R402Hmod P < 0.0001) (Fig. 5e). We did observe an increase in the levels of Tuba1c in R402Hmod/R402Hmod animals, but this increase was not significant (n = 5; +/+ vs. R402Hmod/R402Hmod P > 0.5) (Fig. 5b–d,f–h). Collectively these data show that modifying the mRNA sequence of Tuba1a drastically reduces transcript levels.
Discussion
In this study we describe a new Tuba1a mouse line (R402Hmod) which expresses wild-type TUBA1A protein in the absence of Cre recombinase, but employs alternative codons19. We compared these animals to another line that was identical in all respects, except the codon sequence was not modified (R402Hwt). We found that homozygous (R402Hmod/R402Hmod) animals do not survive until birth and present with a severe neurodevelopmental phenotype at E16.5. This is associated with a decrease in the thickness of the CTIP2-positive neuronal layer and PAX6-positive progenitor layer, as well as an increase in the number of apoptotic cells. We assessed the mRNA expression levels of different α-tubulin isoforms at E16.5 in the developing cortex. Strikingly, both heterozygous (R402Hmod/R402H+) and homozygous animals (R402Hmod/R402Hmod) showed a significant reduction in Tuba1a mRNA levels when compared to R402H+/R402H+ controls. The drastic reduction in mRNA levels in homozygous animals suggests that this codon modified allele acts by a hypomorphic mechanism. Indeed, the phenotype we observe at E16.5 is reminiscent of that described by Bittermann and colleagues who generated two CRISPR-mediated Tuba1a mutant lines where the entire gene locus was deleted11. Loss of Tuba1a in both Tuba1ad4304/d4304 and Tuba1ad4262/d4262 mutants was perinatal lethal and E16.5 embryos presented with major cortical malformations. These findings, and the data presented in this study, suggest that the other α-tubulins expressed in the developing brain (Tuba1b, Tuba1c, Tuba4a) are not able to compensate for the loss of Tuba1a.
What might be the underlying cause for the reduction in Tuba1a mRNA levels we observed in R402Hmod/R402Hmod mice? Although the tubulin autoregulatory mechanism seems to depend on the four-initial amino-acids of α- and β-tubulins, we cannot exclude the possibility that the remainder of the transcript plays a role. The altered codons could impair the binding of other proteins that, like TTC5, influence the levels of tubulin mRNAs18. Interestingly, a study in Drosophila has also shown that different codon usage can affect protein structure as it affects the rate of co-translation protein folding21. Given, however, that tubulin folding is mediated by numerous chaperones (e.g., prefoldin, the cytosolic chaperonin CCT and several chaperone proteins termed TBCA-TBCE) we think this is unlikely to underlie the phenotype we observe3,22. One explanation for the reduction in mRNA we observe in the R402Hmod/R402Hmod mice is that synonymous variation in exon 4 creates novel splice acceptor sites, resulting in a transcript with a premature stop codon that is subject to nonsense mediated decay23,24. Indeed there is growing evidence that synonymous point mutations can modulate gene expression levels, by altering splicing in disease states25. The most plausible explanation, however, for the reduction in Tuba1a transcript is a change in the stability of the transcript. It is known that the codon sequence of a particular mRNA molecule can affect its stability and consequently its levels26. The effect of synonymous genetic variation was recently investigated by Shen and colleagues who analysed the effect of 1,866 synonymous mutations in 21 genes in yeast, assessing their effect on fitness and RNA levels. They found that 75% of synonymous mutations were deleterious, which strongly correlated with the relative expression level of the gene27. Highlighting the importance of codon usage in mRNA stability, studies in zebrafish have shown that the use of uncommon synonymous codons plays a critical role in triggering the clearance of maternal mRNA during development, facilitating mRNA degradation28,29. Collectively these studies show that synonymous genetic changes can alter the levels of a transcript by influencing its splicing, folding, stability and/or translation rate.
A further observation of interest in the reduction in PAX6 progenitors that we observe in R402Hmod/R402Hmod mice. This result is intriguing as TUBA1A is largely considered to be a post-mitotic tubulin13. Gloster and colleagues have previously studied the expression of this gene in mice employing a LacZ reporter coupled to the Tα1-Tuba1a promoter. They observed transgene expression from E9.5, with high levels of expression in differentiating and migrating neurons at E13.5 in the developing cortex. They did observe a small subpopulation of transgene positive cells in the ventricular zones but argued that this followed terminal mitosis and preceded the onset of migration13. Coksaygan and colleagues arrived at a similar conclusion when studying the expression of EYFP coupled to the Tα1-Tuba1a promoter14. Employing birth date labelling they were not able to detect any dividing progenitors that were EYFP positive in the developing cortex. In contrast, Sawamoto and colleagues concluded that Tuba1a is expressed in a limited number of progenitors having crossed the Tα1-Tuba1a EYFP line with a Nestin-EGFP driver30. Most recently single cell sequencing of the developing human and mouse brain, indicate that a portion of radial glia and intermediate progenitors express Tuba1a31,32.
In summation we demonstrate that altering the codon sequence of Tuba1a in mice causes a severe neurodevelopmental phenotype, which is associated with a decrease in the number of post-mitotic neurons and apical progenitors. Moreover, it highlights the importance of codon usage when engineering transgenic mice.
Methods
Ethics statement
All experimental protocols in this manuscript were carried out according to legal requirements and were covered by an approved license (M58/006093/2011/14) from the City of Vienna. All methods were carried out in accordance with relevant guidelines and regulations. All methods are reported in accordance with ARRIVE guidelines.
Generation of two R402H Tuba1a mouse lines
Both lines were generated in collaboration with Ozgene (Perth, Australia), taking advantage of their goGermline technology. The targeting constructs were designed carrying either the wild-type sequence of Tuba1a or modified in order to express a distinct codon sequence in exon 4 (BankIt2640849 Tuba1a OP819667, BankIt2642162 Tuba1a OP819668). Following electroporation into C57/BL6 ES cells, the positive clones were screened using Nde I digestion and southern blot analysis. The clones that had successfully incorporated the constructs, were injected into blastocysts and the resulting chimeras were backcrossed to C57/BL6 animals. Animals from both lines were genotyped using PCR amplification with the primers as described19. We sequenced the entire Tuba1a locus of both mouse lines using genomic DNA samples and two sets of primers to amplify and sequence the locus: mTuba1a_F1/GGATGCAAAGTCTACGGATG and mTuba1a _R1/ATCTCCTTGCCAATGGTGTA, together with mTuba1a_F2/GAAGGGTGAGTGAGCTTGTG and mTuba1a_R2/AAAGCACACATTGCCACATA. All mice were housed at the animal research laboratories of the Institute of Molecular Pathology on a 14:10 h light:dark cycle, with food and water provided ad libitum.
Histological studies
E16.5 embryos (n = 5 for each line) were decapitated and drop-fixed in a solution of 4% paraformaldehyde (Carl Roth, 0335.3). Following fixation overnight, the heads were dehydrated using 30% sucrose and embedded in Neg-50 Frozen Section Medium (Thermo Fisher Scientific, 6502) before storage at − 80 °C. Littermates were sectioned coronally (12 μm thick sections) using a cryostat. Matching sections were chosen and stained with Nissl. Briefly, the slides were washed in PBS before a 3–4 min incubation with Nissl stain (0.1% cresyl violet acetate; Sigma, C5042). The slides were then dehydrated for 3 min in increasing concentrations of ethanol (30%, 70%, 95% and 100%) and transferred to xylol before coverslipping with DPX mounting media. The stained slides were digitized in a Pannoramic 250 Flash II slide scanner (3DHISTECH), equipped with a 20x/0.8 Plan-Apochromat objective.
Immunohistochemistry
Prior to staining, brain sections from littermate mice were matched based on morphological landmarks and selected for further analysis. Cryosections allowed to equilibrate to room temperature overnight. Antigen retrieval was performed a distinct subset of antibodies where stipulated. Slides with cryosections were briefly washed 3 times in PBS before being placed in a coplin jar with the antigen retrieval buffer (Vector Laboratories, H-3301-250). Slides were heated in a water bath to 95 °C. Slides were then removed and allowed to cool for room temperature for 45 min. Sections were washed 3 times 10 min before incubation with blocking/permeabilisation solution for 1 h at room temperature. Following this, the permeabilization solution was removed and sections were incubated with the primary antibody diluted in blocking solution at 4 °C overnight. Primary antibodies were used at the following dilutions: Ctip2 (Abcam, ab18465, 1:300) , Pax6 (Covance, PRB-278P, 1:400), cleaved-caspase 3 (Cell Signaling, 9661S, 1:500). The following day, sections were washed 3 times for 10 min each in PBS before incubation with secondary antibody (diluted 1:1000) and DAPI at room temperature for 2 h. Sections were washed a final time in PBS for 10 min 3 times before mounting in fluorescent mounting media (S3023, DAKO) .
mRNA extraction, cDNA preparation and qPCR
mRNA was extracted from the cortices of E16.5 embryos (n = 5 for each line), snap-frozen using liquid nitrogen. For this, we followed the instructions of a commercially available kit (RNeasy Mini Kit, 74,104, Qiagen). Subsequently, the cDNA was synthesized using a different kit (QuantiTect Reverse Transcription Kit, Qiagen, 205,313). To quantify the levels of the most highly expressed α-tubulin genes in the mouse brain—Tuba1a, Tuba1b, Tuba1c and Tuba4a, we used SYBR green (SsoAdvanced Universal SYBR Green Supermix, 1,725,272, Biorad) on a Biorad CFX 384 Real Time Cycler. We used the following primers: mTuba1a_qPCR_IS_1F/TCTCTTACATCGACCGCCTAA and mTuba1a_qPCR_IS_1R/GCCAACATGGATGGAGATG, mTuba1b_qPCR_IS_1F/TCTCTCACCCTCGCCTTCTA and mTuba1b_qPCR_IS_1R/AGCTGCTCAGGATGGAAGAG, mTuba1c_qPCR_IS_1F/GCGGACCACTTCAAGGACTA and mTuba1c_qPCR_IS_1R/AGCTGCTCAGGATGGAAGAG, mTuba4a_qPCR_IS_1F/CGTACAGCCCAAACTCATCAT and mTuba4a_qPCR_IS_1R/AGAAGGTGGTGAAGGAGTCGT. In addition, we used three control genes: Hprt (Hprt_qPCR_F/GAACCAGGTTATGACCTAGATTTGTT and Hprt_qPCR_R/CAAGTCTTTCAGTCCTGTCCATAAT), Tfrc (Tfrc_qPCR_F/TCGCTTATATTGGGCAGACC and Tfrc_qPCR_R/ATCCAGCCTCACGAGGAGT) and Pgk1 (Pgk1_qPCR_F/AAAGTCAGCCATGTGAGCACT and Pgk1_qPCR_R/ACTTAGGAGCACAGGAACCAAA). We compared three different genotypes and performed all reactions in technical triplicates. For each of the mouse lines, we ran all biological replicates (n = 5) together in one 384-well plate (1 plate per line). The 384-well plates were set up using an Agilent Bravo LT96 Liquid Handling system. We calculated the geometric mean of the Ct values for the three control genes and determined the ΔCt (difference to the mean of the Ct values for each tubulin gene assessed). The relative mRNA expression levels were calculated using the qPCR primer efficiency (between 95 and 105%) as previously described33.
Statistical analysis
The statistical analysis was performed using the GraphPad Prism software (v8.0.2). To analyse our qPCR data, we employed a two-way repeated measures ANOVA, with a Tukey’s multiple comparisons test. We performed one-way ANOVA with Tukey’s multiple comparison test to analyse the number of Pax6 and Ctip2-positive cells between different genotypes. Quantitation of cleaved-caspase-3-postive cells was performed using Brown-Forsythe and Welch ANOVA tests and Dunnett's T3 multiple comparisons test. A summary of the statistical tests used in this study is included in Supplementary Material Table S1. All samples and animals used in this study were not subject to randomization but were assigned to experimental groups based on their genotype. All quantitation was performed blind to genotype.
Supplementary Information
Acknowledgements
Thanks are owed to the Vienna Biocenter Campus and Boehringer Ingelheim for supporting basic research. D.A.K. has received grants from the Austrian Science Fund (P29483, I 2681). A.W.P. is a DOC Fellow supported by the Austrian Academy of sciences. Thanks to OzGene for creating both the R402HWT and R402Hmod mutant mice.
Author contributions
I.L. and D.A.K designed the study, I.L., A.W.P., L.U., and T.C. performed the experiments, I.L. and A.W.P. undertook the statistical analysis, I.L. and A.W.P. prepared the figures, I.L. and D.A.K. wrote the manuscript, all authors reviewed the manuscript.
Funding
Open Access funding enabled and organized by Projekt DEAL.
Data availability
The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request. The DNA sequences of the Tuba1a locus in our mice have been deposited on Genbank (BankIt2640849 Tuba1a OP819667, BankIt2642162 Tuba1a OP819668).
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-023-27782-2.
References
- 1.Cowan NJ, Dudley L. International Review of Cytology. Academic Press; 1983. Tubulin isotypes and the multigene tubulin families; pp. 147–173. [DOI] [PubMed] [Google Scholar]
- 2.Mitchison T, Kirschner M. Dynamic instability of microtubule growth. Nature. 1984;312:237–242. doi: 10.1038/312237a0. [DOI] [PubMed] [Google Scholar]
- 3.Lewis SA, Tian G, Cowan NJ. The α- and β-tubulin folding pathways. Trends Cell Biol. 1997;7:479–484. doi: 10.1016/S0962-8924(97)01168-9. [DOI] [PubMed] [Google Scholar]
- 4.Poirier K, et al. Large spectrum of lissencephaly and pachygyria phenotypes resulting from de novo missense mutations in tubulin alpha 1A ( TUBA1A ) Hum. Mutat. 2007;28:1055–1064. doi: 10.1002/humu.20572. [DOI] [PubMed] [Google Scholar]
- 5.Keays DA, et al. Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans. Cell. 2007;128:45–57. doi: 10.1016/j.cell.2006.12.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kumar RA, et al. TUBA1A mutations cause wide spectrum lissencephaly (smooth brain) and suggest that multiple neuronal migration pathways converge on alpha tubulins. Hum. Mol. Genet. 2010;19:2817–2827. doi: 10.1093/hmg/ddq182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Aiken J, Buscaglia G, Bates EA, Moore JK. The α-tubulin gene TUBA1A in brain development: A key ingredient in the neuronal isotype blend. J. Dev. Biol. 2017;5:8. doi: 10.3390/jdb5030008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Bahi-Buisson N, et al. Refinement of cortical dysgeneses spectrum associated with TUBA1A mutations. J. Med. Genet. 2008 doi: 10.1136/jmg.2008.058073. [DOI] [PubMed] [Google Scholar]
- 9.Tischfield MA, Cederquist GY, Gupta ML, Engle EC. Phenotypic spectrum of the tubulin-related disorders and functional implications of disease-causing mutations. Curr. Opin. Genet. Dev. 2011;21:286–294. doi: 10.1016/j.gde.2011.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Gartz Hanson M, et al. Novel α-tubulin mutation disrupts neural development and tubulin proteostasis. Dev. Biol. 2016;409:406–419. doi: 10.1016/j.ydbio.2015.11.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bittermann E, et al. Differential requirements of tubulin genes in mammalian forebrain development. PLoS Genet. 2019;15:1–28. doi: 10.1371/journal.pgen.1008243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Gloster A, El-Bizri H, Bamji SX, Rogers D, Miller FD. Early induction of Talpha1 alpha-tubulin transcription in neurons of the developing nervous system. J. Comp. Neurol. 1999;405:45–60. doi: 10.1002/(SICI)1096-9861(19990301)405:1<45::AID-CNE4>3.0.CO;2-M. [DOI] [PubMed] [Google Scholar]
- 13.Gloster A, et al. The T alpha 1 alpha-tubulin promoter specifies gene expression as a function of neuronal growth and regeneration in transgenic mice. J. Neurosci. 1994;14:7319–7330. doi: 10.1523/JNEUROSCI.14-12-07319.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Coksaygan T, et al. Neurogenesis in Tα-1 tubulin transgenic mice during development and after injury. Exp. Neurol. 2006;197:475–485. doi: 10.1016/j.expneurol.2005.10.030. [DOI] [PubMed] [Google Scholar]
- 15.Ben-Ze’ev A, Farmer SR, Penman S. Mechanisms of regulating tubulin synthesis in cultured mammalian cells. Cell. 1979;17:319–325. doi: 10.1016/0092-8674(79)90157-0. [DOI] [PubMed] [Google Scholar]
- 16.Cleveland DW, Lopata MA, Sherline P, Kirschner MW. Unpolymerized tubulin modulates the level of tubulin mRNAs. Cell. 1981;25:537–546. doi: 10.1016/0092-8674(81)90072-6. [DOI] [PubMed] [Google Scholar]
- 17.Gasic I, Boswell SA, Mitchison TJ. Tubulin mRNA stability is sensitive to change in microtubule dynamics caused by multiple physiological and toxic cues. PLOS Biol. 2019;17:e3000225. doi: 10.1371/journal.pbio.3000225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Lin Z, et al. TTC5 mediates autoregulation of tubulin via mRNA degradation. Science. 2020;367:100–104. doi: 10.1126/science.aaz4352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Leca I, et al. A proteomic survey of microtubule-associated proteins in a R402H TUBA1A mutant mouse. PLOS Genet. 2020;16:e1009104. doi: 10.1371/journal.pgen.1009104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Hausrat TJ, Radwitz J, Lombino FL, Breiden P, Kneussel M. Alpha- and beta-tubulin isotypes are differentially expressed during brain development. Dev. Neurobiol. 2020 doi: 10.1002/dneu.22745. [DOI] [PubMed] [Google Scholar]
- 21.Fu J, et al. Codon usage affects the structure and function of the Drosophila circadian clock protein PERIOD. Genes Dev. 2016;30:1761–1775. doi: 10.1101/gad.281030.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Vainberg IE, et al. Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin. Cell. 1998;93:863–873. doi: 10.1016/S0092-8674(00)81446-4. [DOI] [PubMed] [Google Scholar]
- 23.Supek F, Miñana B, Valcárcel J, Gabaldón T, Lehner B. Synonymous mutations frequently act as driver mutations in human cancers. Cell. 2014;156:1324–1335. doi: 10.1016/j.cell.2014.01.051. [DOI] [PubMed] [Google Scholar]
- 24.Nickless A, Bailis JM, You Z. Control of gene expression through the nonsense-mediated RNA decay pathway. Cell Biosci. 2017;7:26. doi: 10.1186/s13578-017-0153-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Mueller WF, Larsen LSZ, Garibaldi A, Hatfield GW, Hertel KJ. The silent sway of splicing by synonymous substitutions. J. Biol. Chem. 2015;290:27700–27711. doi: 10.1074/jbc.M115.684035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Novoa EM, Ribas de Pouplana L. Speeding with control: Codon usage, tRNAs, and ribosomes. Trends Genet. 2012;28:574–581. doi: 10.1016/j.tig.2012.07.006. [DOI] [PubMed] [Google Scholar]
- 27.Shen X, Song S, Li C, Zhang J. Synonymous mutations in representative yeast genes are mostly strongly non-neutral. Nature. 2022;606:725–731. doi: 10.1038/s41586-022-04823-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Mishima Y, Tomari Y. Codon usage and 3’ UTR length determine maternal mRNA stability in zebrafish. Mol. Cell. 2016;61:874–885. doi: 10.1016/j.molcel.2016.02.027. [DOI] [PubMed] [Google Scholar]
- 29.Bazzini AA, et al. Codon identity regulates mRNA stability and translation efficiency during the maternal-to-zygotic transition. EMBO J. 2016;35:2087–2103. doi: 10.15252/embj.201694699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Sawamoto K, et al. Direct isolation of committed neuronal progenitor cells from transgenic mice coexpressing spectrally distinct fluorescent proteins regulated by stage-specific neural promoters. J. Neurosci. Res. 2001;65:220–227. doi: 10.1002/jnr.1145. [DOI] [PubMed] [Google Scholar]
- 31.Nowakowski TJ, et al. Spatiotemporal gene expression trajectories reveal developmental hierarchies of the human cortex. Science. 2017;358:1318–1323. doi: 10.1126/science.aap8809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Di Bella DJ, et al. Molecular logic of cellular diversification in the mouse cerebral cortex. Nature. 2021;595:554–559. doi: 10.1038/s41586-021-03670-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Braun A, et al. Tuba8 is expressed at low levels in the developing mouse and human brain. Am. J. Hum. Genet. 2010;86:819–822. doi: 10.1016/j.ajhg.2010.03.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Nakamura Y, Gojobori T, Ikemura T. Codon usage tabulated from international DNA sequence databases: Status for the year 2000. Nucl. Acids Res. 2000;28:292. doi: 10.1093/nar/28.1.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request. The DNA sequences of the Tuba1a locus in our mice have been deposited on Genbank (BankIt2640849 Tuba1a OP819667, BankIt2642162 Tuba1a OP819668).